Mannheim, Germany

Tim Waterboer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2012.


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tim Waterboer: Innovator in HPV Detection

Introduction

Tim Waterboer is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of human papillomavirus (HPV) genotypes. His work has implications for improving health outcomes through better diagnostic methods.

Latest Patents

Tim Waterboer holds a patent for a composition comprising an oligonucleotide mixture for improved detection of human papillomavirus genotypes. This invention relates to a composition that includes an oligonucleotide mixture, which is utilized for diagnosing various HPV genotypes in a sample from a subject. The patent also encompasses a method for diagnosing different HPV genotypes and a kit designed to carry out this method. He has 1 patent to his name.

Career Highlights

Throughout his career, Tim Waterboer has worked with several prominent organizations. He has been associated with the German Cancer Research Center (DKFZ), Stiftung Des Öffentlichen Rechts, and the German Cancer Research Center. His work in these institutions has allowed him to advance his research and contribute to the field of cancer diagnostics.

Collaborations

Tim has collaborated with notable colleagues, including Markus Schmitt and Michael Pawlita. These collaborations have further enriched his research and development efforts in the field of HPV detection.

Conclusion

Tim Waterboer is a distinguished inventor whose work in HPV detection has the potential to enhance diagnostic accuracy and improve patient care. His contributions to medical science are invaluable and continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…